Skip to content
HowShorted

Avita Medical, Inc. short interest in 2025

In 2025, Avita Medical, Inc.'s disclosed short interest ran from 6.91% of shares outstanding on 15 Jan 2025 to 10.19% on 31 Dec 2025, a change of +3.28 percentage points. The year's high was 22.03% on 31 Jul 2025 and its low 6.55% on 28 Feb 2025, averaging 12.82% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.03 days on 15 Oct 2025. Full history: Avita Medical, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Avita Medical, Inc. in 2025

2025 in figures

Start of year
6.91% (15 Jan 2025)
End of year
10.19% (31 Dec 2025)
Change
+3.28 pp
High
22.03% (31 Jul 2025)
Low
6.55% (28 Feb 2025)
Average
12.82%
Highest days to cover
24.03 (15 Oct 2025)
SEC filings marked
9

Every report in 2025

Avita Medical, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20256.91%5.06results (8-K)
31 Jan 20256.90%11.90
14 Feb 20257.36%9.1910-K filed, results (8-K)
28 Feb 20256.55%8.93
14 Mar 20258.91%9.24
31 Mar 20259.30%15.71
15 Apr 202510.60%11.33
30 Apr 202511.29%23.92
15 May 202513.91%9.1010-Q filed, results (8-K)
30 May 202514.98%15.28
13 Jun 202516.97%13.31
30 Jun 202520.73%16.97
15 Jul 202521.58%20.70
31 Jul 202522.03%22.40
15 Aug 202520.21%9.73results (8-K), 10-Q filed
29 Aug 202517.27%14.87
15 Sep 202517.02%2.11
30 Sep 202512.44%6.92
15 Oct 202511.89%24.03
31 Oct 202510.92%8.57
14 Nov 20259.89%17.3610-Q filed, results (8-K)
28 Nov 20259.89%13.96
15 Dec 20259.95%16.53
31 Dec 202510.19%14.53

See also: Avita Medical, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.